Stay updated on Pediatric Ph+ CML Clinical Trial.

Sign up to get notified when there's something new on the Pediatric Ph+ CML Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric Ph+ CML Clinical Trial. page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T13:21:48.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the page’s 403 error.
    Difference
    1%
    Check dated 2026-10-25T13:05:55.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T13:27:42.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:35:31.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the study record area, with a Home link, rather than study information.
    Difference
    0.5%
    Check dated 2026-10-04T15:48:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen with a basic header and a Home link. The previously visible study content has been removed, as shown by the deletions list of detailed study data and related links.
    Difference
    21%
    Check dated 2026-09-20T19:54:45.000Z thumbnail image

Stay in the know with updates to Pediatric Ph+ CML Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pediatric Ph+ CML Clinical Trial. page.